A 35-year-old man with tuberculosis on anti-TB therapy develops high fever, widespread blistering, and skin detachment involving 35% of body surface area with severe mucosal involvement and systemic toxicity. Causative drug is identified and withdrawn. What is the preferred initial pharmacological intervention?